Clinical trials - Press Releases

Date	Title	Company
11-Aug-2023	Lytix Biopharma’s licensing partner Verrica Pharmaceuticals Inc. reports interim Phase 2 data with LTX-315	Lytix Biopharma
10-Aug-2023	Phastar Appoints Graham Clark as New Chief Executive Officer	Phastar
09-Aug-2023	AlzeCure publishes the positive clinical results from the phase I trial of NeuroRestore ACD856 against Alzheimer's	AlzeCure Pharma AB
09-Aug-2023	RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award	CluePoints
03-Aug-2023	TrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing Initiative	TrialAssure
03-Aug-2023	Innovative Trials shortlisted for prestigious British Business Excellence Award	Innovative Trials
02-Aug-2023	Theriva™ Biologics Announces Key Progress in VIRAGE, an Ongoing, Multinational Phase 2b Trial of VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma	Theriva™ Biologics
01-Aug-2023	Expert Speaker Lineup Revealed for Award Winning RBQM Event	CluePoints
01-Aug-2023	The Portrait Project gives clinical trial patients a platform to share their unique experiences and influence change	Mural Health
25-Jul-2023	Evidence from Electronic Health Records-to-Electronic Data Capture live pilot study	IgniteData
22-Jul-2023	27th International Conference on Advanced Nanoscience and Nanotechnology	Allied Academies
21-Jul-2023	Toppan Holds VIRTUAL REMIX JAPAN™ Metaverse Event	Toppan
21-Jul-2023	Are shared medical appointments the key to solving global healthcare shortages?	ESMT Berlin
21-Jul-2023	Molecure completes successful Secondary Public Offering (SPO) of approximately PLN 50 million (USD 12 million) with proceeds to be used to fund and build a first in class, sustainable pipeline of breakthrough therapies	Molecure S.A.
21-Jul-2023	Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis	Tillotts Pharma
21-Jul-2023	The Science-Based Targets Initiative (SBTi) validates Almirall's 2030 emission reduction targets and its goal of achieving net zero emissions by 2050	Almirall
21-Jul-2023	Teva UK launches GoResp® Digihaler® (budesonide/ formoterol), the first integrated digital inhaler system for appropriate adult patients with asthma and COPD[i] in the UK	Teva UK Limited
21-Jul-2023	Researchers aim for rapid biomarker diagnostic test for stroke, using saliva	University of Birmingham
21-Jul-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study	HUTCHMED
21-Jul-2023	Healthcasts Introduces ConsensusAI, the First AI-Powered, Real-Time Patient Consultation Tool for Healthcare Professionals	Healthcasts